Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.

Sicknesses advance one next to the other with human development and assume critical part in wellbeing. Alongside the cultural and mechanical turn of events, humankind additionally faces extraordinary difficulties in wellbeing area. One of these difficulties is the progressions in sickness appearance, its fix and clearly its impact on living life forms particularly people, which has deteriorate over the natural course of time. A portion of the infections are effectively treatable now while other still postures intricacies. Skin malignant growth is one of the most well-known and broad tumors in spite of mechanical and restorative progressions and requests tenacious consideration.

Keywords:Genetic factors; Skin cancer; Diagnosis; Treatment; Metastasis

Skin disease is fundamentally harmed skin cells which continue to develop strangely. Upon each open to UV radiation, perilous material and destructive synthetic compounds, there is a fair opportunity of primary and utilitarian changes in skin cells, which thusly prompts skin malignant growth. With the progression of time, these harms become more serious and more regrettable. Monotonous openings further increment the disease risk. At whatever stage in life, many sun security items help in avoidance of skin malignant growth and melanoma [1]. Skin malignant growth is named after the cell type in which the disease extends. There are three significant kinds of skin disease:

1. Basal cell carcinoma

2. Squamous cell carcinoma

3. Melanoma

Basal and squamous cell carcinoma are non-melanoma diseases, however melanoma is most serious kind of skin malignant growth. Melanoma incorporates Merkel cell cancer and dermato-fibrosarcomaprotruberans. Like all diseases, early determination of skin malignant growth brings about better treatment. Region of the skin which is disease impacted appears to be unique from the other body parts. Indeed, even a little flaw ought to be treated in a serious way and it is vital for be looked at. Skin disease normally looks as new flaw. Now and then it shows up as introduced spot which get in various variety, shape or size [2]. In white populace, Melanoma skin malignant growth (MSC) and Non melanoma skin disease (NMSC) are the fundamental sorts of skin malignant growth. Pervasiveness of skin malignant growth has achieved pandemic greatness. As of late directed examinations on populace has showed that the basal cell carcinoma's occurrence rate in guys is more than 2% while that for squamous cell carcinoma is 1%, and pace of new instances of melanoma is around 50 for each 100 000 of populace [3].

Basal cell carcinoma is broadly spread malignant growth type however not perilous one. It for the most part seems to be a dry scale or piece of pale or red tone having slow development rate. It is normally seen on neck, head and upper middle [3]. With continuous development, it prompts ulcer which doesn't mend totally. Indeed, even after recuperating, there is a fair opportunity briefly episode. Squamous cell carcinoma is likewise not a significant wellbeing danger when contrasted with different types of malignant growth. If there should arise an occurrence of carelessness, it can spread to other body parts. The development require months when open to sun. It shows up as textured flaw of red tone. This imperfection can drain or ulcerate without any problem. Both these Non-Melanoma Skin Diseases (NMSC) are not perilous as Melanoma Skin Malignant growth (MSC) [3-5].

It is the most risky sort of skin disease with a quick development recurrence. Whenever dismissed, it can prompt serious perilous structure in six weeks or less. It shows up as level smudge on skin as a rule having various varieties - brown, blue, dark, dim or red, not typically open to sun [5].

An incredibly perilous sort of melanoma shows up uniquely in contrast to common melanomas - it is outrageous all along. It shows up as red, pink, dark or earthy colored flaws. It develops rapidly and can be perilous in the event of carelessness or on the other hand whenever left unattended. A few innocuous codes of sun harmed skin are spots, moles, marks, stains, flaws, spots, and blotches and so on [5,6].

Among skin malignant growth, larger part of cases are either basal or squamous cells carcinoma. These sorts don't spread to other body part. In the event that untreated, brings about deforming locally. Melanomas are named harmful assuming they spread to other body parts. It is of modest number and very forceful malignant growth. If untreated, brings about existence danger [2]. Skin malignant growths start as the precancerous sores. At first these injuries are not carcinogenic yet can change into disease with the progression of time. It is medicinally alluded as dysplasia. Actinic keratosis develops into squamous cell carcinoma [7]. Nevus is a mole which strangely forms into dysplastic nevi. Dysplastic-nevi are not genuine malignant growth, but rather can change into the genuine disease. Normally individuals have numerous moles on the body, around 10 to 30, which might show up as smooth, raised, round in structure, tan or skin-hued, and not more than quarter-inch in size. At times, individuals have 100 or considerably more dysplastic-nevi, which are awry in shape, with serrated borders and "pebbly", one ought to go to their medical care place, in the event that they notice any adjustment of typical moles on the skin [8].

Daylight is significant gamble factor for skin disease. Bright Radiation (UVR) is naturally lively constituent of daylight. The incredibly cancer-causing scope of UVR is 290-320 nm Bright B (UVB) while 320-400 nm Bright A (UVA) is lesser cancer-causing [9,10]. Other gamble factors for skin malignant growth includes diet, stress, chemical treatment, hair colors, smoking, fluorescent lighting. Utilization of tanning parlors and sun beds are additionally the reason for melanoma [11]. Different causes incorporate immuno-concealment, or mutilation of resistant framework [12]. Disclosure to X-beams or other undeniable level radiations can foster skin disease, even openness to specific synthetics, like arsenic and hydrocarbons in oils, tar, or sediment bring about carcinoma. Individuals on incomparable gamble of melanoma are those with blonde skin, which spots, sun related burn without any problem. Those with straw colored hair, blue or green eyes, strange orabundant moles, past history of treated disease and history of skin malignant growth in nearest relative are at more serious gamble of skin malignant growth improvement [13]. Hereditary issues that cause consumption of skin shade, for instance albinism and xerodermapigmentosum can bring about skin malignant growth movement in those individuals [14]. Age can be one more component of basal and squamous cell carcinomas. However, mature doesn't explicitly have anything to do with melanomas and it can foster in youngsters around 25 to 29 years of age. [15].

Hardly any different qualities are additionally viewed as inactivated during skin cancer advancement. Reclamation of their appearance brings about the cancer concealment and incited apoptosis. p53 is one such quality which is really a pressure prompted record factor and in around half of all SCCs, different inactivating changes causes its practical inactivation [43]. FOS and c-Jun are the individuals from the record factor complex AP-1whose raised levels in growth cells are accounted for to help melanoma improvement by choking the p53tumor-suppressive capability through direct transcriptional restraint [44,45]. Other than that planning of a few powerlessness loci for cutaneous harmful melanoma (CMM) have been finished. CMM1 powerlessness loci are accounted for to be situated on chromosome 1p36, changes in the CDKN2A quality on chromosome 9p21 is accounted for related with CMM2 and transformations in the CDK4 quality on chromosome12q14 are accounted for related with CMM3. CMM4 has been connected to chromosome 1p22 [46]. However, these vulnerability loci planning isn't sufficient, further review is expected to find more loci connected to this disease. A few qualities like STK11, BRAF, DCC, TRRAP, PTEN, BAP1, ZNF831 and GRIN2A have been accounted for to contain irregular physical transformations which might be the reason for harmful melanoma [47]. These qualities require further concentrate inside and out to figure out the sub-atomic impacts of these transformations on quality item and further impact on cell's ordinary physiology prompts growth.

Various symptoms are present depending on the type of skin cancer. When exposed to sunlight, BCC can develop as a raised, smooth, glossy bump or an uncurable sore on the head, neck, or shoulders. Even blood vessels can occasionally be seen, and tumours frequently develop ulcerations. SCC appears as a well-defined, scaly, thickened bash when exposed to sunlight. Ulcerations can grow into huge masses if they are not treated. Melanomas can vary in size, form, atypical moles, and pigmented ulceration that ranges from brown to black. In maturity, it can also manifest as a newly developed mole, itching, or ulceration [48].

Biopsies and physical examinations are used to identify skin cancer. In a medical biopsy, a portion or the entire mole is taken and sent to the lab for the procedure. Results might be acquired within a week because it is an efficient and straightforward diagnostic approach. Getting a mole or lesion evaluated by a dermatologist is a good option for early diagnosis because a mole or lesion could turn into skin cancer. Dermatologists follow a straightforward process; after carefully examining the lesion using Mela Find, they determine whether it is malignant using computer-simulated image evaluation [49]. After that, a biopsy sample is obtained for under-the-microscope examination. Additional blood tests and a chest X-ray are performed if the biopsy results in malignant melanoma [50].

Age and general wellbeing are two significant situations to be considered for best treatment. Therapy can likewise rely on type, size, shape and spread of the malignant growth. Ordinarily clear techniques, for example, medical procedure, freezing and scratching are utilized for BCC and SCC therapy [51,52]. Additionally, skin creams (Imiquimod treatment) [53], skin photodynamic treatment (PDT) [54] and cytostatic specialist 5-fluorouracil [55] have been endorsed for non-melanomacancer therapy. For harmful melanoma complex strategies for treatment are required, for example, immunotherapy, chemotherapy and radiotherapy intervened treatment [50]. Various methods i.e., straightforward extraction, electrodesiccation and curettage, and cryosurgery are utilized to eliminate the little injuries of skin disease [56]. Mohs micrographic medical procedure is utilized to eliminate the bigger growths, repetitive cancers and sores in cosmetically delicate regions and high-risk areas. In this strategy, the tissue is eliminated cautiously, layer by layer, till the presence of malignant growth free tissue [57,58]. Generally skin malignant growth seeks relieved after careful treatment. Of the skin malignant growths that do return, the vast majority of them do as such inside the time of three years.

In the event of cutting edge threatening melanoma, one ought to counsel their oncologist like clockwork. Territorial lymph hub checks, occasional chest X-beams and body sweeps and absolute body skin tests ought to be done during these visits [59]. Confirmations from epidemiological examinations demonstrate that abstaining from smoking and extraordinary sun openness, controlling the diseases, lessening of liquor utilization, expanded admission of leafy foods, and expansion in actual work will successfully decrease the paces of malignant growth [60-62]. IFN-α assists in supporting the resistant framework and help with evacuation of the extra melanoma cells post-medical procedure. Its antitumor movement in cutting edge malignant growth problems is an additional benefit [63]. Vismodegib, a hedgehog flagging pathway inhibitors has demonstrated surprisingly productive and ended up being proficient therapy choice for patient with skin tumors. If situations where a growth is hazardous to work or the radiation treatment isn't fitting, vismodegib therapy has brought about complete reduction in 21% of privately progressed BCC [64]. The use of nanotechnologies for plenty of biomedical applications has ignited recent fad overall [65]. Nanomaterials have been investigated broadly to work on the intensity of anticancer therapy utilizing designated drug conveyance [66]. An assortment of nanomaterials have been investigated for their likely job to treat skin malignant growth. A few key models incorporate use of dendrimers, liposomes, polymersomes, protein based nanoparticles, inorganic nanoparticles and carbon-based nanoparticles as cutting edge conveyance frameworks for designated anticancer therapy systems [67].

As time passes, skin disease is turning into the essential explanation of a few everyday passing's. One of the significant reasons for its event is openness to UVR which much of the time, one can't keep away from. Thus, rather than recommending thoughts to limit sun openness like the utilization of sun block creams which cause more damage than great, researcher should find normal sources which kill UVR impact. Vitamin D in such manner has tentatively shown to be extremely compelling in limiting the possibilities of skin cancer advancement and furthermore in smothering growth development. The treatment and analytic procedures additionally need improvement as early discovery of cancer have its advantages in giving opportune appropriate therapy. Further, chemo-and radio-treatment are customary approaches to treating diseases which are not explicit and patients need to go through numerous actual changes that are exceptionally humiliating and deterring for them. This brings down the patient confidence as well as impacts recuperation rate. Present day treatment strategies incorporate skin creams and immunotherapy which are less difficult and are more well defined for cancers. Even more enhancements are expected in the therapy of skin malignant growth.

1.Gordon R (2013) Skin cancer: an overview of epidemiology and risk factors in Seminars in oncology nursing. Semin Oncol Nurs 29:160-169.

2.Suárez B, López-Abente G, Martínez C, Navarro C, Tormo MJ, Rosso S, et al. (2007) Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study. BMC Public Health Vol: 7.

3.Diepgen, TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146: 1-6.

4.Preston DS, Stern RS (1992) Nonmelanoma cancers of the skin. N Engl J Med 327: 1649-1662.

5.Gloster HM, Neal K (2006) Skin cancer in skin of color. J Am Acad Dermatol 55: 741-760.

6.Shaikh WR, Xiong M, Weinstock MA (2012) The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. Arch Dermatol 148: 30-36.

7.Lalji A, Khiroya N, Lalji M (2014) Actinic Keratosis and Squamous Cell Carcinoma. Clin Res Dermatol Open Access 1: 1-3.

8.Duffy K, Grossman D (2012) The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. Journal of the American Academy of Dermatology 67: e11-e16.

9.Green AC, O'Rourke MG (1985) Cutaneous malignant melanoma in association with other skin cancers. Journal of the National Cancer Institute. 74: 977-980.

10.Urbach F (1993) Environmental risk factors for skin cancer. Skin Carcinogenesis in Man and in Experimental Models, pp: 243-262.

11.Armstrong BK (1988) Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 14: 835-849.

12.Beissert S, Schwarz T (1999) Mechanisms involved in ultraviolet light-induced immunosuppression. J Investig Dermatol Symp Proc Nature Publishing Group

13.Breitbart EW, Greinert R, Volkmer B (2006) Effectiveness of information campaigns. Progress in Biophysics and Molecular Biology 92: 167-172.

14.Saladi RN, Persaud AN (2005) The causes of skin cancer: a comprehensive review. Drugs Today (Barc) 2005. 41: 37-54.

15.Epstein JH (1983) Photocarcinogenesis, skin cancer, and aging. J Am Acad Dermatol 9: 487-502.

16.Sheehan D, Meade G, Foley VM, Dowd CA (2001) Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360: 1-16.

17.YuanJ-M, Chan KK, Coetzee GA, Castelao JE, Watson MA, et al. (2008) Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis 29: 1386-1393.

18.Lei Z, Liu T, Li X, Xu X, Fan D (2015) Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer. Int J Clin Exp Med 8: 377-386.

19.Lira MG, Provezza L, Malerba G, Naldi L, Remuzzi G, et al. (2006) Glutathione S-transferase and CYP1A1 gene polymorphisms and non‐melanoma skin cancer risk in Italian transplanted patients. Experimental Dermatology 15: 958-965.

20.Chiyomaru K, Nagano T, Nishigori C (2011) Polymorphisms of Glutathione S-Transferase in Skin. Kobe J Med Sci 57: E11-E16.

21.Fryer AA, Ramsay HM, Lovatt TJ, Jones PW, Hawley CM, et al. (2005) Polymorphisms in Glutathione S-Transferases and Non-Melanoma Skin Cancer Risk in Australian Renal Transplant Recipients. Carcinogenesis 26: 185-191.

22.Sankar S, Tanner JM, Bell R, Chaturvedi A, Randall RL, et al. (2013) A Novel Role for Keratin 17 in Coordinating Oncogenic Transformation and Cellular Adhesion in Ewing Sarcoma. Mol Cell Biol 33: 4448-4460.

23.Fulton AM (2009) The Chemokine Receptors CXCR4 and CXCR3 in Cancer. Curr Oncol Rep 11: 125-131.

24.DePianto D, Kerns ML, Dlugosz AA, Coulombe PA (2010) Keratin 17 Promotes Epithelial Proliferation and Tumor Growth by Polarizing the Immune Response in Skin. Nat Genet 42: 910-914.

25.Chung BM, Arutyunov AE, Ilagan E, Yao N, Wills-Karp M, et al. (2015) Regulation of CXC Chemokine Gene Expression by Keratin 17 and hn RNP K in Skin Tumour Keratinocytes. J Cell Biol 208: 613-627.

26.Lee MH, Kim MO, Lee SY, Sung-Young L, Seung HS, et al. (2015) Genetic Ablation of Caspase-7 Promotes Solar-Simulated Light-Induced Mouse Skin Carcinogenesis: The Involvement of Keratin-17. Carcinogenesis 36: 1372-1380.

27.Peng L, Ran YL, Hu H, Yu L, Liu Q, et al. (2009) Secreted LOXL2 is a Novel Therapeutic Target That Promotes Gastric Cancer Metastasis via the Src/FAK Pathway. Carcinogenesis 30: 1660-1669.

28.Fujimoto E, Tajima S (2009) Reciprocal Regulation of LOX and LOXL2 Expression during Cell Adhesion and Terminal Differentiation in Epidermal Keratinocytes. J Dermatol Sci 55: 91-98.

29.Martin A, Salvador F, Moreno Bueno G, Floristán A, Ruiz‐Herguido C, et al. (2015) Lysyl Oxidase Like 2 Represses Notch1 Expression in the Skin to Promote Squamous Cell Carcinoma Progression. The EMBO Journal.

30.Brooks YS, Ostano P, Jo SH, Dai J, Getsios S, et al. (2014) Multifactorial ERβ and NOTCH1 Control of Squamous Differentiation and Cancer. J Clin Invest 124: 2260-2276.

31.Segre JA, Bauer C, Fuchs E (1999) Klf4 is a Transcription Factor Required for Establishing the Barrier Function of the Skin. Nat Genet 22: 356-360.

32.Shields JM, Christy RJ, Yang VW (1996) Identification and Characterization of a Gene Encoding a Gut-Enriched Kruppel-Like Factor Expressed During Growth Arrest. J Biol Chem 271: 20009-20017.

33.Yoon HS, Ghaleb AM, Nandan MO, Hisamuddin IM, Dalton WB, et al. (2005) Kruppel-Like Factor 4 Prevents Centrosome Amplification Following γ-Irradiation-Induced DNA Damage. Oncogene 24: 4017-4025.

34.Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC (2008) Nuclear Kruppel-Like Factor 4 Expression is Associated with Human Skin Squamous Cell Carcinoma Progression and Metastasis. Cancer Biol Ther 7: 777-782.

35.Webb AR (2006) Who, What, Where and When-Influences on Cutaneous Vitamin D Synthesis. Prog Biophys Mol Biol 92: 17-25.

36.Grant WB, Cross HS, Garland CF, Gorham ED, Moan J, et al. (2009) Estimated Benefit of Increased Vitamin D Status in Reducing the Economic Burden of Disease in Western Europe. Prog Biophys Mol Biol 99: 104-113.

37.Grant WB (2010) Relation Between Prediagnostic Serum 25-Hydroxyvitamin D Level and Incidence of Breast, Colorectal, and other Cancers. J Photochem Photobiol B 101: 130-136.

38.Holick MF (2006) High Prevalence of vitamin D Inadequacy and Implications for Health. In Mayo Clinic Proceedings, Elsevier.

39.Tang JY, Parimi N, Wu A, Boscardin WJ, Shikany JM, et al. (2010) Inverse Association Between Serum 25 (OH) Vitamin D Levels and Non-Melanoma Skin Cancer in Elderly Men. Cancer Causes Control 21: 387-391.

40.Eisman JA, Barkla DH, Tutton PJ (1987) Suppression of in Vivo Growth of Human Cancer Solid Tumour Xenografts by 1, 25-Dihydroxyvitamin D3. Cancer Research 47: 21-25.

41.Danielsson C, Fehsel K, Polly P and Carlberg C (1998) Differential apoptotic response of human melanoma cells to 1, 25-dihydroxyvitamin D~ 3 and its analogues. Cell Death and Differentiation 5: 946-952.

42.Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Molecular oncology 5: 197-214.

43.Sarasin A and Giglia‐Mari (2002) G p53 gene mutations in human skin cancers. Experimental dermatology, 11: 44-47.

44.Stepniak E, Ricci R, Eferl R (2006) c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes & Development 20: 2306-2314.

45.Kolev V, Mandinova A, Guinea-Viniegra J, Sumara G, Sumara I, et al. (2008) EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nature Cell Biology 10: 902-911.

46.Tsuchiya H, Tomita K, Ohno M, Inaoki M and Kawashima A (1991) Werner's syndrome combined with quintuplicate malignant tumors: a case report and review of literature data. Japanese Journal of Clinical Oncology 21: 135-142.

47.Robertson KD, Jones PA (1999) Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene 18.

48.Narayanan DL, Saladi RN, Fox JL (2010) Review: Ultraviolet radiation and skin cancer. International Journal of Dermatology 49: 978-986.

49.Stanganelli I, Brucale A, Calori L, et al. (2005) Computer-aided diagnosis of melanocytic lesions. Anticancer Research. 25: 4577-4582.

50.Madan V, Lear JT and Szeimies RM (2010) Non-melanoma skin cancer. The Lancet 375: 673-685.

51.Randle HW (1996) Basal Cell Carcinoma Identification and Treatment of the High‐Risk Patient. Dermatologic Surgery 22: 255-261

52.Thissen MR, Neumann MH, Schouten LJ (1999) A systematic review of treatment modalities for primary basal cell carcinomas. Archives of Dermatology 135: 1177-1183.

53.Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, et al. (2005) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from a randomized vehicle‐controlled phase III study in Europe. British Journal of Dermatology 152: 939-947.

54.Szeimies R, Ibbotson S, Murrell D, Rubel D, Frambach Y, et al. (2008) A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up. Journal of the European Academy of Dermatology and Venereology 22: 1302-1311.

55.Roozeboom M, Nelemans P, Mosterd K, Steijlen P and Arits A, et al. (2015) Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a non-inferiority randomized controlled trial. British Journal of Dermatology 172: 739-745.

56.Sheridan AT, and Dawber RP (2001) Curettage, electrosurgery and skin cancer. Australasian Journal of Dermatology 41: 19-30.

57.Shriner DL, McCoy DK, Goldberg DJ and Wagner RF (1998) Mohs micrographic surgery. Journal of the American Academy of Dermatology 39: 79-97.

58.Mosterd K., Krekels GA, Nieman FH, Ostertag JU, Essers BA, et al. (2008) Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. The Lancet Oncology, 9: 1149-1156.

59.Roozeboom M, Arits A, Nelemans P and Kelleners‐Smeets N (2012) Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta‐analysis of randomized and nonrandomized trials. British Journal of Dermatology 167: 733-756.

60.Ames BN, Gold LS and Willett WC (1995) the causes and prevention of cancer. Proceedings of the National Academy of Sciences 92: 5258-5265.

61.Leonard DG, Bagg A, Caliendo AM, Deerlin VM, Kaul KL (2007) Molecular pathology in clinical practice 223 Springer.

62.Hill D, White V, Marks R, Borland R (1993) Changes in sun-related attitudes and behaviours, and reduced sunburn prevalence in a population at high risk of melanoma. European Journal of Cancer Prevention 2: 447-456.

63.Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U (2015) “Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, 26: v126-v132.

64.Zoe A, Dorothee N, Richard BW, Xavier C (2017) Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. Dermatology and Therapy January 7: 5-19.

65.Lucas BN, Chetna D, Jayarama RV, Lakshminarayanan R, Seeram RK, et al. (2017) Nanotechnology for the treatment of melanoma skin cancer. Progress in Biomaterials 6: 13-26.

66.Jiezhong C, Renfu S, Xu DZ, Chen (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. International Journal of Nanomedicine 8: 2677-2688.

67.Dianzani C, Zara GP, Maina G, Pettazzoni P, Pizzimenti S et al. (2014) “Drug delivery nanoparticles in skin cancers,” BioMed Research International, 1-13.

Ullah Jan S .Skin cancer genetics Assessment and Therapy. World Journal Of Hematology And Oncology 2022.